Brief: Diasorin, Fy Adjusted EBITDA Eur 394 Mln
March 14 (Reuters) - DiaSorin SpA DIAS.MI: FY REVENUE EUR 1.2 BILLION FY ADJUSTED EBITDA EUR 394 MILLION FY NET PROFIT EUR 187 MILLION SEES 2025 ADJUSTED EBITDA MARGIN AT AROUND 34% SEES 2025 REVENUE EX COVID AT AROUND +8% PROPOSES DIVIDEND OF EUR 1.20 PER SHARE Further company coverage: DIAS.MI (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on DiaSorin SpA
See all newsKepler sees European Medtech recovery, starts BioMerieux at 'Buy' as top pick
Brief: Diasorin Receives Us' FDA 510(K) Clearance And Clia Waiver For Liaison Nes Group A Streptococcus (Gas) Assay
Deutsche Bank cuts Diasorin to 'sell', sees company targets as stretched
Italy - Factors to watch on June 5
Italy's DiaSorin jumps after Betaville reports possible takeover interest